Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.34 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.33 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.33 |
| ▸ | FHIT | P49789 | 5/20 | 0.33 |
| ▸ | DTYMK | P23919 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24258634 | 1.00 | BCHE (0.35) | BCHEPOLBENPP1P2RY1RNASEL | |
| SCHEMBL24258666 | 0.92 | POLB (0.37) | BCHEPOLBENPP1P2RY1RNASEL | |
| SCHEMBL24258655 | 0.90 | BCHE (0.34) | BCHEPOLBENPP1P2RY1RNASEL | |
| SCHEMBL24258605 | 0.83 | POLB (0.36) | BCHEPOLBENPP1P2RY1FHIT | |
| SCHEMBL24258665 | 0.82 | FHIT (0.39) | BCHEP2RY1RNASELFHIT | |
| SCHEMBL24258615 | 0.81 | RNASEL (0.38) | BCHEPOLBENPP1P2RY1RNASEL | |
| SCHEMBL24258659 | 0.75 | ENPP1 (0.41) | POLBENPP1P2RY1RNASELDTYMK | |
| SCHEMBL24258606 | 0.72 | POLB (0.42) | BCHEPOLBENPP1P2RY1RNASEL | |
| SCHEMBL21263871 | 0.71 | POLB (0.49) | POLBENPP1P2RY1RNASELFHIT | |
| SCHEMBL20691275 | 0.70 | BCHE (0.52) | BCHEPOLBENPP1P2RY1FHIT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3752516-B1 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2022-02-23 | — | — | EP | disclosed |